Harnessing the Potential of Combination Immunotherapy and Oncolytic Virotherapy for Solid Tumors

by Boland, G.M, Cohen, S.
Published 2022

Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy

by Andreatta, M., Barras, D., Benedetti, F., Berthold, D.R, Bourhis, J., Carmona, S.J, Corria-Osorio, J., Coukos, G., Crespo, I., Dafni, U., de Olza, M.O, Dimopoulou, G., Dromain, C., Duran, R., Foukas, P., Genolet, R., Ghisoni, E., Harari, A., Herrera, F.G, Imbimbo, M., Irving, M., Kandalaft, L.E, Laniti, D.D, Messemaker, M., Orcurto, A., Pittet, M.J, Prior, J., Rodrigo, B.N, Ronet, C., Rusakiewicz, S., Sarivalasis, A., Schaefer, N., Sempoux, C., Smith, T., Spill, A., Tsourti, Z., Warren, S.E, Zaman, K., Zimmermann, S.
Published 2022

Immunotherapy for early triple negative breast cancer: research agenda for the next decade

by Andrè, F., Bianchini, G., Cortes, J., Corti, C., Curigliano, G., Mittendorf, E.A, Rugo, H., Schmid, P., Tarantino, P., Tolaney, S.M
Published 2022

Characterization of the immune response in patients with cancer of the oral cavity after neoadjuvant immunotherapy with the IRX-2 regimen

by Bellile, E., Bryan Bell, R., Campos, C.Z, Cernea, C.R, Cruz, F.J.S.M, D'Silva, N., Erman, A., Girotto, G.C, Higgins, K., Kaplan, M., Kraus, D., Krempl, G., Liu, S., Martins, W.A, McCaul, J., Moyer, J., Newman, J., Nguyen, A., Nieva, J., Oliveira, F., Panwar, A., Patel, M., Rozek, L., Sartor, M.A, the INSPIRE Trial Clinical Investigators, Valentino, J., Victorina, A.P, Wolf, G.T, Zarins, K.
Published 2021

HIF activation enhances FcγRIIb expression on mononuclear phagocytes impeding tumor targeting antibody immunotherapy

by Beers, S.A, Booth, S.G, Carter, M.J, Chee, S.J, Cleary, K.L.S, Cragg, M.S, Cutress, R.I, Dahal, L.N, Douglas, J., Foxall, R.B, French, R.R, Frendéus, B., Ghorbani, M., Glennie, M.J, Hargreaves, C.E, Hussain, K., James, S., Kemp, R.S, Liu, R., Longley, J., Macari, S., Markham, H., Müller, K.T.J, Murray, T., Oldham, R.J, Ottensmeier, C.H, Roghanian, A., Smith, R.C.G, Stopforth, R.J, Strefford, J.C, Thirdborough, S.M
Published 2022

Dysregulated ferroptosis-related genes indicate potential clinical benefits for anti–PD-1/PD-L1 immunotherapy in lung adenocarcinoma

by Chen, Y., Li, T., Zhang, X., Zhou, M.
Published 2021

A mutation-based gene set predicts survival benefit after immunotherapy across multiple cancers and reveals the immune response landscape

by Bian, J., Chen, P., Lin, Y., Long, J., Sang, X., Wang, A., Wang, D., Yang, X., Zhang, H., Zhao, H., Zheng, M., Zheng, Y.
Published 2022

Optimal target saturation of ligand-blocking anti-GITR antibody IBI37G5 dictates FcγR-independent GITR agonism and antitumor activity

by Cao, L., Chen, B., Chia, T., Fu, F., Guan, J., He, K., He, L., Kuang, Z., Liu, H., Liu, X., Lu, J., Shao, Z., Sun, G., Wang, J., Wang, Z., Wu, D., Wu, M., Wu, W., Wu, Z., Xu, W., Yao, Y., Zhou, S.
Published 2022

Dependency of EGFR activation in vanadium-based sensitization to oncolytic virotherapy

by Alluqmani, N., Arulanandam, R., Bergeron, A., Chen, A., Diallo, J.-S, Maznyi, G., Wong, B.
Published 2022

Real-world evidence for option value in metastatic melanoma

by Garrison, L.P., Jr, Lee, W., Li, M., To, T.M, Veenstra, D.L, Wong, W.B
Published 2021

Combined tumor and immune signals from genomes or transcriptomes predict outcomes of checkpoint inhibition in melanoma

by Aguet, F., Arniella, M.B, Barzily-Rokni, M., Blackmon, S.M, Blaum, E.M, Boland, G.M, Carrot-Zhang, J., Chen, J.H, Duncan, L.M, Elagina, L., Flaherty, K.T, Frederick, D.T, Freeman, S.S, Gabriel, S., Getz, G., Gonye, A.L.K, Gushterova, I., Ha, G., Hacohen, N., Hammond, M.R, Jiao, Y.J, Kim, J., LaSalle, T.J, Lawrence, D.P, Leshchiner, I., Lin, Z., Livitz, D., Meyerson, M., Ravi, A., Rosebrock, D., Sade-Feldman, M., Sharova, T., Spiro, O.G, Stemmer-Rachamimov, A.O, Stewart, C., Sullivan, R.J, Vitzthum von Eckstaedt, H.C, Wargo, J.A, Yizhak, K.
Published 2022

Tumor-Localized Administration of α-GalCer to Recruit Invariant Natural Killer T Cells and Enhance Their Antitumor Activity against Solid Tumors

by Fang, Y., Hon, R., Kramer, A., Li, Y.-R, Wilson, M., Yang, L., Zhou, Y., Zhu, Y.
Published 2022

ISOTOPE: ISOform-guided prediction of epiTOPEs in cancer

by Eyras, E., Fugmann, T., Pérez-Granado, J., Reixachs-Solé, M., Sanz, F., Trincado, J.L, Yokota, J.
Published 2021

CAR T Cell Therapy in Primary Brain Tumors: Current Investigations and the Future

by Lim, M., Lin, Y.-J, Mashouf, L.A
Published 2022

G6PD functions as a metabolic checkpoint to regulate granzyme B expression in tumor-specific cytotoxic T lymphocytes

by Colby, A.H, Colson, Y.L, Ding, H.-F, Grinstaff, M.W, Klement, J.D, Liu, K., Lu, C., Oberlies, N.H, Pearce, C.J, Shi, H., Yang, D.
Published 2022

Sinonasal mucosal melanoma extended to nose bridge: A one-time reconstruction treatment report

by Abbate, V., Califano, L., Cieri, M., Dell'Aversana Orabona, G., Iaconetta, G., Mascolo, M., Pansini, A., Romano, A., Salzano, G.
Published 2018

STK11 Loss: A Novel Mechanism for Melanoma Metastasis with Therapeutic Implications

by Azin, M., Demehri, S.
Published 2022

Renin–angiotensin–aldosterone system inhibitors and survival in patients with hypertension treated with immune checkpoint inhibitors

by Drobni, Z.D, Gilman, H.K, Jain, R.K, Merkely, B., Michielin, O., Muller, V., Neilan, T.G, Pittet, M.J, Quinaglia, T., Reynolds, K.L, Sullivan, R.J, Supraja, S., Zlotoff, D.A, Zubiri, L.
Published 2022

British Association of Head and Neck Oncologists (BAHNO) standards 2020

by Ahmed, O., Brennan, P.A, Cook, F., Garrett, M., Homer, J., Hughes, C., Kerawala, C., Mayland, C., Mihai, R., Newbold, K., O’Hara, J., Roe, J., Schache, A., Sibtain, A., Smith, M., Thavaraj, S., Weller, A., Winter, L., Winter, S.C, Young, V.
Published 2021

Novel insights into the roles and therapeutic implications of MUC1 oncoprotein via regulating proteins and non-coding RNAs in cancer

by Che, J., Han, Y., Kufe, D., Li, W., Li, X., Sun, C., Yao, X., Zheng, J.
Published 2022